Abstract
The pharmacokinetics of a single oral dose of dihydrocodeine were studied in nine patients with chronic renal failure treated by haemodialysis and nine subjects with normal renal function. In the patients the mean peak plasma dihydrocodeine concentration occurred later and the area under the curve was greater than in the normal subjects. Furthermore, the drug was still detectable after 24 hours in all the patients but only three of the normal subjects. These data, together with those obtained from previously published clinical case reports, contradict the traditional view that the body's ability to cope with opioid drugs is not altered in renal failure.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLER T. K., FUJIMOTO J. M., WAY E. L., BAKER E. M. The metabolic fate of codeine in man. J Pharmacol Exp Ther. 1955 Jul;114(3):251–262. [PubMed] [Google Scholar]
- Barnes J. N., Goodwin F. J. Dihydrocodeine narcosis in renal failure. Br Med J (Clin Res Ed) 1983 Feb 5;286(6363):438–439. doi: 10.1136/bmj.286.6363.438-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bennett W. M., Aronoff G. R., Morrison G., Golper T. A., Pulliam J., Wolfson M., Singer I. Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis. 1983 Nov;3(3):155–193. doi: 10.1016/s0272-6386(83)80060-2. [DOI] [PubMed] [Google Scholar]
- Bianchetti G., Graziani G., Brancaccio D., Morganti A., Leonetti G., Manfrin M., Sega R., Gomeni R., Ponticelli C., Morselli P. L. Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet. 1976;1(5):373–384. doi: 10.2165/00003088-197601050-00004. [DOI] [PubMed] [Google Scholar]
- Cheigh J. S. Drug administration in renal failure. Am J Med. 1977 Apr;62(4):555–563. doi: 10.1016/0002-9343(77)90418-1. [DOI] [PubMed] [Google Scholar]
- Don H. F., Dieppa R. A., Taylor P. Narcotic analgesics in anuric patients. Anesthesiology. 1975 Jun;42(6):745–747. doi: 10.1097/00000542-197506000-00021. [DOI] [PubMed] [Google Scholar]
- Hug C. C., Jr, Mellett L. B., Cafruny E. J. Stop-flow analysis of the renal excretion of tritium-labeled dihydromorphine. J Pharmacol Exp Ther. 1965 Nov;150(2):259–269. [PubMed] [Google Scholar]
- McQuay H., Moore A. Metabolism of narcotics. Br Med J (Clin Res Ed) 1984 Jan 21;288(6412):237–237. doi: 10.1136/bmj.288.6412.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moore A., Sear J., Baldwin D., Allen M., Hunniset A., Bullingham R., McQuay H. Morphine kinetics during and after renal transplantation. Clin Pharmacol Ther. 1984 May;35(5):641–645. doi: 10.1038/clpt.1984.88. [DOI] [PubMed] [Google Scholar]
- Olsen G. D., Bennett W. M., Porter G. A. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther. 1975 Jun;17(6):677–684. doi: 10.1002/cpt1975176677. [DOI] [PubMed] [Google Scholar]
- Reidenberg M. M. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med. 1977 Apr;62(4):466–470. doi: 10.1016/0002-9343(77)90398-9. [DOI] [PubMed] [Google Scholar]
- Reidenberg M. M. The biotransformation of drugs in renal failure. Am J Med. 1977 Apr;62(4):482–485. doi: 10.1016/0002-9343(77)90401-6. [DOI] [PubMed] [Google Scholar]
- Schäli C., Roch-Ramel F. Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney. J Pharmacol Exp Ther. 1982 Dec;223(3):811–815. [PubMed] [Google Scholar]
- Ventkateswaran P. S., Jeffers A., Hocken A. G. Gastric acid secretion in chronic renal failure. Br Med J. 1972 Oct 7;4(5831):22–23. doi: 10.1136/bmj.4.5831.22. [DOI] [PMC free article] [PubMed] [Google Scholar]